Bivalirudin use in acute coronary syndrome patients undergoing percutaneous coronary interventions in Poland: Clinical update from expert group of the Association on Cardiovascular Interventions of the Polish Cardiac Society
Open Access
- 14 March 2019
- journal article
- research article
- Published by VM Media Group sp. z o.o in Cardiology Journal
- Vol. 26 (1) , 1-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Safety and efficacy of switching from unfractionated heparin to bivalirudin during primary percutaneous coronary interventionCatheterization and Cardiovascular Interventions, 2018
- Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trialThe Lancet, 2018
- Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet TherapyJACC: Cardiovascular Interventions, 2015
- Anticoagulants: A Review of the Pharmacology, Dosing, and ComplicationsCurrent Emergency and Hospital Medicine Reports, 2013
- Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial InfarctionJAMA, 2012
- Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of non–ST-segment elevation acute coronary syndromesValue in Health, 2011
- Bivalirudin during Primary PCI in Acute Myocardial InfarctionNew England Journal of Medicine, 2008
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2007
- Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-Receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: A decision-analytic modelClinical Therapeutics, 2006
- Bivalirudin for Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2006